This multicenter retrospective cohort study assessed a nomogram integrating habitat heterogeneity, peritumoral (3 mm) radiomic features, and clinical variables for risk stratification in 290 patients with locally advanced rectal cancer. The primary outcome was the ability to identify high-risk disease, with secondary outcomes including AUC, sensitivity, specificity, and decision curve analysis.
In the training cohort, the nomogram showed excellent performance with an AUC of 0.928. In the test cohort, performance remained excellent with an AUC of 0.817. Model comparison indicated that logistic regression classifiers outperformed SVM classifiers, and the model utilizing habitat/peritumoral (3 mm) features demonstrated superior performance compared to intratumoral/peritumoral (1 mm) features. Calibration analysis revealed good agreement between predicted and observed high-risk LARC cases. Decision curve analysis showed higher net benefit across a broad range of threshold probabilities.
Safety, tolerability, adverse events, discontinuations, and serious adverse events were not reported. The study design was retrospective, and follow-up duration was not reported. Funding or conflicts of interest were not reported. While the model may facilitate precise risk stratification and personalized total neoadjuvant therapy decision-making for LARC, the observational nature of the data limits causal inference.
View Original Abstract ↓
BackgroundRisk stratification is essential for optimizing treatment in locally advanced rectal cancer (LARC), particularly for identifying suitable candidates for total neoadjuvant therapy (TNT). Conventional MRI-based staging has limited sensitivity in capturing tumor microenvironment (TME) heterogeneity, which may lead to undertreatment of high-risk patients or overtreatment of low-risk subgroups. This study aimed to develop a nomogram integrating MRI-based habitat heterogeneity and peritumoral radiomics to improve risk stratification in LARC.MethodsA multicenter retrospective cohort of 290 LARC patients (training set, n=178; external test set, n=112) was analyzed. Tumor volumes and peritumoral regions (1, 2, and 3 mm margins) were delineated on high-resolution MRI scans using 3D Slicer. Habitat heterogeneity was quantified via K-means clustering (k=3) of intratumoral radiomic features. Radiomic features were filtered and reduced using LASSO regression. Logistic regression (LR) and support vector machine (SVM) classifiers were used to build intratumoral, peritumoral, and habitat models. The better-performing model between the intratumoral and habitat models was combined with the optimal peritumoral model and clinical variables to construct a nomogram. Calibration curves assessed agreement between predicted and observed high-risk LARC. Model performance was evaluated using area under the curve (AUC), sensitivity, specificity, and decision curve analysis (DCA).ResultsLR classifiers outperformed SVM classifiers and were therefore selected for the intratumoral, peritumoral, and habitat models. The habitat and peritumoral (3 mm) models showed superior performance compared with the intratumoral and peritumoral (1 mm) models and were integrated with clinical variables into a nomogram. The nomogram achieved excellent performance in both training (AUC, 0.928) and test cohorts (AUC, 0.817), surpassing single-feature models. Calibration curves demonstrated good agreement between predicted and observed high-risk LARC. DCA showed the nomogram provided higher net benefit across a broad range of threshold probabilities.ConclusionBy characterizing the spatial heterogeneity of the tumor microenvironment, an MRI-derived nomogram integrating habitat heterogeneity, peritumoral (3 mm) radiomic features, and clinical variables was developed to facilitate precise risk stratification and personalized TNT decision-making for LARC.